Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.

about

Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.

Item

http://www.wikidata.org/entity/Q48507719

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@en

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@nl

type

Item

label

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@en

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@nl

altLabel

Antiplatelet Therapy in ACS Pa ...... he Use of New P2Y12 Inhibitors

@en

prefLabel

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@en

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@nl

P1476

Antiplatelet Therapy in ACS Pa ...... e Use of New P2Y12 Inhibitors.

@en

P2093

Benjamin Marchandot

http://www.w3.org/2001/XMLSchema#string

Jessica Ristorto

http://www.w3.org/2001/XMLSchema#string

Laurence Jesel

http://www.w3.org/2001/XMLSchema#string

Marion Kibler

http://www.w3.org/2001/XMLSchema#string

Michael Schaeffer

http://www.w3.org/2001/XMLSchema#string

Nathan Messas

http://www.w3.org/2001/XMLSchema#string

Nicolas Meyer

http://www.w3.org/2001/XMLSchema#string

Nicolas Tuzin

http://www.w3.org/2001/XMLSchema#string

Olivier Morel

http://www.w3.org/2001/XMLSchema#string

Patrick Ohlmann

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.

Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.

Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions.

Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.

Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

P304

674-689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5551/JAT.40584

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29415954

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

P932

6099071

http://www.w3.org/2001/XMLSchema#string